22.3 Shock Drugs

Shock Drugs

Shock occurs when tissues don't receive enough oxygen and nutrients to function, and without rapid intervention, it progresses to organ failure and death. Shock drugs restore perfusion by targeting the underlying cause: replacing lost volume, strengthening the heart's pump, or tightening blood vessels to raise pressure. This section covers the three major shock types you'll encounter, the drugs used for each, and the nursing priorities that keep patients safe during treatment.

Characteristics and Uses of Drugs for Anaphylactic, Hypovolemic, and Cardiogenic Shock

Each type of shock has a different root cause, so the drug strategy differs for each.

Anaphylactic shock is a severe, systemic allergic reaction that causes massive vasodilation and bronchoconstriction. Treatment targets all three problems simultaneously:

• Epinephrine is the first-line drug. It works on multiple receptor types at once: alpha-1 stimulation causes vasoconstriction (raises blood pressure), beta-1 stimulation increases heart rate and contractility (improves cardiac output), and beta-2 stimulation relaxes bronchial smooth muscle (opens the airway). Given IM in the anterolateral thigh for most patients; IV for cardiac arrest or refractory cases.
• Antihistamines like diphenhydramine block H1 histamine receptors, reducing itching, hives, and further vasodilation. These are adjuncts, not replacements for epinephrine.
• Corticosteroids such as methylprednisolone suppress the inflammatory and immune response. They take hours to work, so they're given to prevent a biphasic (delayed second-wave) reaction, not to treat the acute crisis.

Hypovolemic shock results from significant fluid or blood loss. The priority is volume replacement:

• Crystalloids (normal saline, lactated Ringer's) are first-line. They expand intravascular volume quickly and are inexpensive. Lactated Ringer's is often preferred for large-volume resuscitation because its electrolyte composition is closer to plasma.
• Colloids such as albumin contain large molecules that stay in the vascular space longer, helping maintain oncotic pressure. They're used when crystalloids alone aren't enough.
• Blood products (packed red blood cells, fresh frozen plasma, platelets) replace what's actually been lost in hemorrhagic shock. PRBCs specifically restore oxygen-carrying capacity.

Cardiogenic shock occurs when the heart fails as a pump, most often after a large myocardial infarction. Treatment aims to improve cardiac output while supporting blood pressure:

• Inotropes like dobutamine (beta-1 agonist) and milrinone (phosphodiesterase inhibitor) strengthen cardiac contraction and improve output. Dobutamine is typically first-line.
• Vasopressors like norepinephrine increase systemic vascular resistance to maintain blood pressure when it drops dangerously low. Dopamine may also be used, though norepinephrine is generally preferred in current guidelines.
• Vasodilators such as nitroglycerin reduce preload and afterload, decreasing the heart's workload and improving coronary blood flow. These are used cautiously because they can worsen hypotension.

Actions, Side Effects, and Drug Interactions of Common Shock Medications

Epinephrine

• Actions: Vasoconstriction (alpha-1), increased heart rate and contractility (beta-1), bronchodilation (beta-2)
• Side effects: Tachycardia, hypertension, anxiety, tremors, palpitations. At high doses, risk of myocardial ischemia.
• Key interactions: Beta-blockers can blunt its cardiac and bronchodilatory effects. MAO inhibitors potentiate its action and can cause a hypertensive crisis. Alpha-blockers oppose its vasoconstrictive effects.

Norepinephrine

• Actions: Potent vasoconstriction (strong alpha-1 agonist) with mild beta-1 stimulation. Raises blood pressure primarily by increasing systemic vascular resistance.
• Side effects: Hypertension, tissue ischemia (especially if it extravasates), arrhythmias, decreased renal perfusion at high doses.
• Key interactions: Tricyclic antidepressants block norepinephrine reuptake, intensifying its effects. Beta-blockers and alpha-blockers can alter the expected hemodynamic response.

Dobutamine

• Actions: Primarily a beta-1 agonist that increases cardiac contractility and output. Has mild beta-2 effects that can cause slight vasodilation.
• Side effects: Tachycardia, arrhythmias, and paradoxical hypotension (from the vasodilatory beta-2 effect, especially at higher doses).
• Key interactions: Beta-blockers directly oppose its mechanism. MAO inhibitors can intensify its effects.

Vasopressin

• Actions: Acts on V1 receptors in vascular smooth muscle to cause vasoconstriction independent of adrenergic receptors. This makes it useful when catecholamine vasopressors aren't working well (as in septic shock).
• Side effects: Hypertension, decreased cardiac output, mesenteric and digital ischemia, hyponatremia (due to its antidiuretic effect).
• Key interactions: Concurrent use with other vasoconstrictors increases ischemia risk. Diuretics and drugs affecting the renin-angiotensin system (ACE inhibitors, ARBs) can have altered effects when combined with vasopressin.

Key Nursing Considerations When Administering Shock Drugs

1. Assess hemodynamic status continuously. Monitor blood pressure, heart rate, MAP (mean arterial pressure), and cardiac output. Watch for signs of inadequate tissue perfusion: decreased urine output (less than 0.5 mL/kg/hr), altered mental status, cool/mottled extremities, and rising lactate levels.

2. Use the correct IV access and infusion equipment. Vasopressors like norepinephrine should run through a central venous catheter when possible. Always use an infusion pump for titrated drips. Never run vasopressors or inotropes as gravity infusions.

3. Titrate to target parameters. Most vasopressors are titrated to a target MAP (commonly ≥65 mmHg). Know the ordered parameters and adjust the drip rate accordingly. Document each titration change.

4. Monitor for adverse effects at every assessment. Check for arrhythmias on the cardiac monitor, assess IV sites for signs of extravasation (blanching, swelling, pain), and watch for end-organ ischemia (chest pain, decreased urine output, abdominal pain).

5. Ensure proper medication safety. Verify drug concentration and dose with a second nurse for high-alert medications. Label all infusion lines clearly. Never abruptly discontinue vasopressors; taper them gradually as the patient stabilizes.

6. Document thoroughly. Record the drug, dose, route, infusion rate, and every rate change. Note the patient's hemodynamic response and any adverse effects. This documentation is critical for tracking trends and guiding treatment decisions.

Patient Education Strategies for Individuals Prescribed Shock Medications

Most shock drugs are given in acute, emergent settings where the patient may be too unstable for detailed teaching. Education often happens during recovery or at discharge.

• Explain the purpose of the medications in simple terms. For example: "This medication is helping keep your blood pressure high enough so your organs get the oxygen they need." Patients who understand why they're receiving a drug are more likely to report symptoms and cooperate with monitoring.
• Teach patients to recognize and report concerning symptoms. Chest pain, palpitations, sudden headache, numbness or tingling in extremities, and difficulty breathing should all be reported immediately. For patients discharged with an epinephrine auto-injector, teach proper injection technique and emphasize that they should still call 911 after using it.
• Encourage questions and open communication. Patients in shock situations are often frightened. Acknowledge that, and invite them to ask about anything they don't understand. Include family members in education when the patient is unable to participate.
• Provide written materials and follow-up resources. Verbal teaching during a crisis is easily forgotten. Give patients written discharge instructions, reliable educational websites, and clear guidance on when to seek emergency care. Refer to support groups or counseling if the experience was traumatic.